IDEAYA Biosciences (IDYA) EBITDA Margin (2020 - 2026)
IDEAYA Biosciences' EBITDA Margin was -1372.96% in Q2 2026, up 271.19 percentage points from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, IDEAYA Biosciences' EBITDA Margin was -91.49% through Jun 30, 2026; for FY2025, it was -71.61%, up 4565.36 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +102.22 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -4636.97% in FY2024 (-4072.71 pp), -564.26% in FY2023 (-445.67 pp), -118.59% in FY2022 (+55.14 pp) and -173.73% in FY2021 (+0.10 pp).
- Quarterly EBITDA Margin has moved between -2050.94% (Q4 2024) and 52.50% (Q3 2025) over five years.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2025 (a gain of 1188.04 percentage points); the worst was Q4 2024 (a drop of 998.21 percentage points).
- Per Business Quant data, IDYA's EBITDA Margin in the three quarters before Q2 2026 was -1644.15% (Q1 2026), -862.90% (Q4 2025) and 52.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | IDEAYA Biosciences | 3.68 Bn | 757.04 Mn | - | -1,372.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,372.96% |
| Mar 31, 2026 | -1,644.15% |
| Dec 31, 2025 | -862.90% |
| Sep 30, 2025 | 52.50% |
| Dec 31, 2024 | -2,050.94% |
| Dec 31, 2023 | -1,052.73% |
| Sep 30, 2023 | -409.13% |
| Jun 30, 2023 | -905.47% |
| Mar 31, 2023 | -326.03% |
| Dec 31, 2022 | -643.59% |
| Sep 30, 2022 | 4.14% |
| Jun 30, 2022 | -375.82% |
| Mar 31, 2022 | -121.10% |
| Dec 31, 2021 | -605.03% |
| Sep 30, 2021 | -125.47% |
| Jun 30, 2021 | -121.14% |
| Mar 31, 2021 | -120.78% |
| Dec 31, 2020 | -46.53% |
| Sep 30, 2020 | -51.85% |
API Access
IDEAYA Biosciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();